IPO Profile: Tokai Pharmaceuticals Inc

The company, backed by Novartis and Novo A/S, raised $69 million in funding

1 October 2014•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.